Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of MYO9B polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
More info about MYO9B polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB7039 |
| Product name: | MYO9B polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of MYO9B. |
| Gene id: | 4650 |
| Gene name: | MYO9B |
| Gene alias: | CELIAC4|MYR5 |
| Gene description: | myosin IXB |
| Immunogen: | A synthetic peptide corresponding to human MYO9B. |
| Immunogen sequence/protein sequence: | C-KNDFEPVKQSKAQ |
| Protein accession: | NP_004136.2 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:2000) Western Blot (2-6 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | MYO9B polyclonal antibody (Cat # PAB7039) (2 ug/mL) staining of human liver lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect.Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, Franke L, van't Slot R, van Belzen MJ, Lavrijsen IC, Diosdado B, Daly MJ, Mulder CJ, Mearin ML, Meijer JW, Meijer GA, van Oort E, Wapenaar MC, Koeleman BP, Wijmenga C. Nat Genet. 2005 Dec;37(12):1341-4. Epub 2005 Nov 13. |